Native Cardio supports a solution to AFib. "Atrial fibrillation, or AFib, is the most common type of irregular heartbeat. About 10.55 million Americans have it. AFib happens when the electrical activity of the heart isn’t working the way it’s supposed to. That causes the heart to quiver and beat in an unpredictable rhythm. AFib can cause the heart to work harder to pump blood through the body. That can lead to heart failure. Because blood doesn’t move through the heart the wa

Postoperative Atrial Fibrillation is a major issue that results in negative outcomes and negative effects on all stakeholders: Patients and their Families, Care Teams and Hosptials, and PayorsPostoperative atrial fibrillation is a critical concern that can lead to severe consequences for all stakeholders involved: patients and their families, healthcare teams and hospitals, as well as payors. Addressing this issue is essential to improving patient outcomes and overall healthc

Cardiovascular disease (CVD) remains the leading cause of global morbidity and mortality. Although substantial therapeutic advances have been made over the past decades, the years 2024–2025 mark a turning point characterized by the emergence of mechanistically innovative, disease-modifying therapies that go beyond conventional risk-factor control. This narrative review aims to synthesize transformative pharmacological and regulatory milestones reshaping contemporary cardiovas

We are pleased to share that the AHA has published the 2025 Guidelines for Cardiopulmonary Resuscitation (CPR) and Emergency Cardiovascular Care (ECC) — a critical update for anyone involved in resuscitation, emergency care, and health systems. cpr.heart.org Why this matters • These Guidelines reflect the latest evidence and have been updated to improve survival rates and neurological outcomes following cardiac arrest. • They emphasize a systems approach combining education,

Amazing to realize the incidence following surgery. POAF following CABG or CABG-valve repair can be as high as 40-60% with no good treatment, except for beta blockers and antirryhtmics like amiodarone. Novel solutions are needed and Native Cardio, Inc. is bringing such innovation to address this unmet need. More to come from our outstanding leadership team. Click to read more:https://www.jacc.org/doi/10.1016/j.jacc.2023.08.017

After an atrial fibrillation (AF) diagnosis, roughly two out of every five patients will develop heart failure, making it a much more frequent complication than stroke, according to a nationwide study from Denmark. Moreover, the burden of heart failure in the AF population has remained constant over the past two decades while lifetime risks of stroke have slightly declined during the direct oral anticoagulant (DOAC) era, Nicklas Vinter, MD, PhD (Aalborg University, Denmark),

Healio (3/27, Schaffer) reports, “An analysis of five U.S. medical claims databases” published online in the journal Clinical Cardiology...

NEW YORK, Nov. 10, 2021 /PRNewswire/ — Peerbridge Health and Native Cardio Inc. recognize the postoperative challenges the 500,000+...

NativeCardio releases new investor video describing the use of its Rhythm Maker device. A special thank you to the doctors and staff at Texas Heart Institute for making this video possible. We believe this video will be well received by potential investors. #science Link to the video: https://www.linkedin.com/posts/joseph-pergolizzi-md-9a81884_nativecardio-just-released-a-new-investor-ugcPost-6830884018565857280-7OT1/?highlightedUpdateUrn=urn%3Ali%3Aactivity%3A683088401888882

Native Cardio is a Proud participant in the prestigious Texas Medical Center Accelerator Program (TMCx) 2020 Fall Bootcamp! Click to Read...

Native Cardio Nominated for Prestigious CiteLine Award as Most Innovative Start-Up Naples-based Company Gets Recognized for Novel Medical...

Joseph Pergolizzi, M.D., President of Native Cardio, Inc., will present the company’s innovative solution to atrial fibrillation at the...

Joseph Pergolizzi, M.D., President of Native Cardio, Inc., will present the company’s innovative solution to atrial fibrillation at the...

Leading Anesthesiologist, Pain and Critical Care Medicine Researcher Joseph Pergolizzi, MD, Recognized as a 2018 Top Doctor

Click To Read Announcement Below Native Cardio, Inc. CEO Dr. Joseph Pergolizzi retires from Johns Hopkins University to focus on advanced...

We are pleased to announce that Native Cardiovascular has been invited to present its direct tissue delivery system at The 9th Annual...

For Immediate Release Native Cardiovascular: